
Treating Obesity
For the study, researchers assigned 26 obese teens ages 12 to 19 to either twice daily injections of Byetta or a placebo. Subjects were instructed to inject the drug once before breakfast, and then once before dinner. After three months, those on the placebo were offered the chance to switch to Byetta. At the end of the study, researchers noted that those who received the Byetta injections for the entirety of the study had a nearly 3 percent greater reduction in their body mass index compared to those on the placebo. Those on Byetta lost about 7 pounds more than those on the placebo. Additionally,
researchers noted that those on the drug had seen a slight decrease in systolic blood pressure, which is important to reducing heart risk factors.
Initially, subjects reported suffering from diarrhea, headaches, and vomiting, but side effects tapered off as the study went on.
Researchers are quick to stress that Byetta has not been approved for weight loss, and probably won’t be for quite some time. But the findings represent an important first step into the possible treatment of obesity in youths. These findings come after the the Food and Drug Administration had approved two new drugs for the treatment of obesity in adults, Belviq and Qysmia.

Image courtesy of Marin / FreeDigitalPhotos.net.

We specialize in providing our over 1,000,000 customers with relevant product and condition information created by our professional editorial staff which includes our team of medical writers, medical practitioners, and health educators. eDrugStore.com Staff on Facebook